Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Adjuvant chemotherapy can impair cognition in women with breast cancer
May 19th, 2005
A study from England shows that adjuvant chemotherapy is associated with higher risk of impaired cognitive function in women with breast cancer than in control groups. "Several studies have reported that chemotherapy-treated patients have impaired cognition function relative to control groups. We are conducting a longitudinal study with cognitive assessments at baseline, 6, and 18 months," reported V. Shilling and colleagues, University of Sussex. "A planned preliminary analysis of data from 50 chemotherapy patients and 43 healthy controls at baseline and post-treatment found a significant group by time interaction on three measures of verbal and...
Source: Women's Health Weekly (2005-05-19)
|
